Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
13F holders, Q4 2022
Institutional positions in Cingulate Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +3 vs. Q3 2022
- Shares held
- 112.4K
- −152.7K (−57.6%) vs. Q3 2022
- Total value
- $112.1K
- −$170.9K (−60.4%) vs. Q3 2022
- New holders
- 5
- 2 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CING on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $9.88M |
| Q1 2026 | 27 | $7.37M |
| Q4 2025 | 18 | $2.23M |
| Q3 2025 | 12 | $1.14M |
| Q2 2025 | 15 | $1.18M |
| Q1 2025 | 9 | $566.1K |
| Q4 2024 | 9 | $447.4K |
| Q3 2024 | 10 | $251.8K |
| Q2 2024 | 10 | $217.1K |
| Q1 2024 | 9 | $128.9K |
| Q4 2023 | 5 | $29.1K |
| Q3 2023 | 20 | $964.5K |
| Q2 2023 | 14 | $400.3K |
| Q1 2023 | 13 | $433.0K |
| Q4 2022 | 11 | $112.1K |
| Q3 2022 | 8 | $283.0K |
| Q2 2022 | 8 | $963.9K |
| Q1 2022 | 6 | $2.13M |
| Q4 2021 | 5 | $3.06M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cingulate Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighTower Advisors, LLC | 34,425 | $34.0K | 0.00% | +34,425 | New |
| Sabby Management, LLC | 22,018 | $22.0K | 0.06% | −95,775−81.3% | Reduced |
| Sterneck Capital Management, LLC | 14,144 | $14.1K | 0.01% | +14,144 | New |
| KC Investment Advisors, LLC | 11,750 | $12.0K | 0.01% | +11,750 | New |
| Creative Planning | 10,919 | $10.9K | 0.00% | +10,919 | New |
| Tower Research Capital LLC (TRC) | 9,113 | $9.00K | 0.00% | −1,856−16.9% | Reduced |
| UBS Group AG | 6,717 | $6.72K | 0.00% | −8,360−55.4% | Reduced |
| GoalVest Advisory LLC | 3,200 | $3.20K | 0.00% | +1,000+45.5% | Added |
| Wells Fargo & Company | 53 | $53 | 0.00% | +1+1.9% | Added |
| Bank of America Corp | 20 | $20 | 0.00% | +20 | New |
| Morgan Stanley | 19 | $19 | 0.00% | −18−48.6% | Reduced |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −107,527−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −11,399−100.0% | Sold out |